Objective: To review evidence on the efficacy of HPV vaccines in the prevention of non-
cancer lesions (anogenital warts [AGW], recurrent laryngeal papillomatosis and oral …

Human papillomavirus (HPV) is the most prevalent sexually transmitted infection worldwide
and ano-genital warts (AGWs) are highly infectious. This virus is transmitted through sexual …

Background Assessing the impact and effectiveness of HPV vaccines on anogenital warts in
the United States can provide early indication of the success of vaccination programs as well …

Human papillomavirus (HPV) vaccines are preventive measures to decrease HPV infection
rates. Knowledge of their efficacy as treatment options for anogenital warts (AGWs) and oral …

Background We assessed the effectiveness of the quadrivalent human papillomavirus
vaccine (qHPV) vaccination program in Manitoba, Canada, in reducing incident anogenital …

Objective The aim of the study was to investigate the effects of 3 or less quadrivalent human
papillomavirus (HPV) vaccine doses on anogenital warts in both males and females in the …

Anogenital warts (AGWs) rank among the most frequent sexually transmitted infections in
young adults. They are benign lesions, but they pose a significant economic cost to health …

The preventive effect of HPV vaccines against anogenital and oropharyngeal cancers has
been proven in both clinical trials and real-world data. We reviewed the published evidence …

Background Human papillomavirus (HPV) infections are associated with common
dermatologic and nondermatologic diseases. Although HPV vaccines are well established …

Objectives To assess the effectiveness of the HPV vaccines in preventing genital warts in
young women. Design Population-based study using health databases. Setting Valencian …